February 2, 2009 - Using a special MRI technique, researchers have determined that the location and degree of airway narrowing in the lungs of asthma sufferers can be markedly persistent over time, according to finds to be published in the February issue of Radiology.

“A considerable number of airways appeared to be consistently narrowed over time,” said the study’s lead author, Eduard E. de Lange, M.D., professor of radiology at the University of Virginia Health Sciences Center. “This finding was irrespective of disease severity or the use of medication.”

Asthma is a chronic inflammatory disorder in which the small and medium-sized airways of the lungs become obstructed. Narrowing or closure in the passages can be caused by swelling in the walls or changes in the structure of the airways as a result of the chronic condition.

For the study, researchers used hyperpolarized helium 3 (3He) MRI to visualize areas of airflow obstruction in the lungs called ventilation defects. To perform the imaging test, patients inhaled the helium gas prior to undergoing MRI.

In order to measure the changes in the location and size of airway defects over time, researchers performed consecutive 3He MRI studies on 43 asthma patients between 18 and 40 years old.

Twenty-six patients underwent two imaging studies on the same day (up to 82 minutes apart), and 17 underwent 3He MRI on three occasions separated by an average of 51 days. In addition to each 3He MRI exam, patients also underwent spirometry, a test that measures the amount of air exhaled from the lungs.

In the same-day examinations, 75 percent of the lung defects identified by 3He MRI remained in the same location for both imaging studies. The majority of those defects, or 71 percent, remained the same size. In the multi-day examinations, 67 percent of defects were still present in studies that were repeated with a median interval of 31 days; in studies with a median interval of 85 days, 38 percent of defects remained in the same location. The findings were not affected by disease severity or by use of asthma medication.

“Most of the change in overall defect number was caused by variability between patients rather than within patients, indicating that 3He MRI provides a reliable means for visualizing airflow impediment within the lungs of patients with asthma,” Dr. de Lange said.

After an interval of about three months, repeat 3He MRI revealed that more than one-third of airway defects were in the same location and approximately one-half of those defects were the same size.

“A considerable number of airways appeared to be consistently narrowed over time, which helps us understand that asthma is largely a focal disease of the lung,” Dr. de Lange said.

For more information: www.rsna.org


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group, led by authors at the University of Toronto, have developed an approach for ...

Time April 23, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Molecular Imaging

March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...

Time March 29, 2024
arrow
News | FDA

March 27, 2024 — SyntheticMR announced that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) ...

Time March 27, 2024
arrow
News | Artificial Intelligence

March 1, 2024 — Royal Philips, a global leader in health technology, and magnetic resonance imaging (MRI) software ...

Time March 01, 2024
arrow
Subscribe Now